13D/13G Filings - Neos Therapeutics Inc. (NEOS)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
08:52 am
Sale
2020-12-3113GNEOS THERAPEUTICS INC
NEOS
Sphera Funds Management Ltd.0
0.000%
-3,530,731decrease
(Position Closed)
Filing
History
2021-02-12
5:07 pm
Purchase
2020-12-3113GNEOS THERAPEUTICS INC
NEOS
Stonepine Capital Management, LLC4,962,657
9.970%
103,768increase
(+2.14%)
Filing
History
2021-02-12
06:47 am
Sale
2020-12-3113GNEOS THERAPEUTICS INC
NEOS
Nantahala Capital Management, LLC0
0.000%
-4,610,000decrease
(Position Closed)
Filing
History
2021-02-11
8:33 pm
Purchase
2020-12-3113GNEOS THERAPEUTICS INC
NEOS
GOLDMAN SACHS & CO. LLC337,247
0.700%
337,247increase
(New Position)
Filing
History